Molecular Diagnostics Market delivers a succinct analysis on industry size, regional growth and revenue forecasts for the upcoming years. The report further sheds light on significant challenges and latest growth strategies adopted by manufacturers who are a part of the competitive spectrum of this business domain.
Increasing number of chronic & infectious diseases and technological advancements are key drivers for Global Molecular Diagnostics Market.
Get Sample of This Report@ https://brandessenceresearch.com/requestSample/PostId/242
Scope of Global Molecular Diagnostics Market Reports –
The term “molecular diagnostics” refers to clinical tests used to identify a disease or the susceptibility to a disease, by analyzing DNA / RNA or their proteins, in humans or in the case of infections, in microbes. Its scope includes the clinical testing devices, as well as their reagents and supplies that are utilized in hospitals, clinics, commercial laboratories, reference laboratories and research institutes to detect cells and proteins for the purpose of diagnosis and monitoring disease. Molecular diagnostics play an important role in infectious disease testing as they provide effective and fast results. So, during the study of Global Molecular Diagnostics Market, we have considered global molecular diagnostics products and consumables to analyze the market.
Key Players for Global Molecular Diagnostics Market Reports-
Global molecular diagnostics market report covers prominent play Bio-Rad Laboratories, Inc., Abbott, Siemens Healthcare GmbH, Alere, Inc., Dako, Bayer AG, Hologic, Inc., Danaher, Sysmex Corporation, Novartis AG, Johnson & Johnson, Qiagen N.V., Becton Dickinson and Company, Roche Diagnostics, BioMerieux SA, Cepheid, Quidel Corporation, Debiopharm Group, Onkogen Diagnostik Sistemler Ltd., Myriad Genetics, Genomic Health, Luminex, GenMark Diagnostics, Biocartis Group and others.
Global molecular diagnostics market report is segmented on the basis of product, technology, application and end user. Based on product global molecular diagnostics market is classified as instruments, reagents and services. Based upon technology, global molecular diagnostics market is classified as PCR (Polymerase Chain Reaction), INAAT (Isothermal Nucleic Acid Amplification Technology), DNA sequencing, hybridization, microarray and others. Based upon applications, global molecular diagnostics market is classified as infectious diseases, chronic diseases, genetic testing, screening and pharmacogenomics. Based upon end user type, global molecular diagnostics market is classified as hospitals, laboratories and research institutes.
The regions covered in this global molecular diagnostics market report are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, market of Global Molecular Diagnostics is sub divided into U.S., Mexico, Canada, U.K., France, Germany, Italy, China, Japan, India, South East Asia, GCC, Africa, etc.
Global Molecular Diagnostics Market Dynamics –
Increasing number of chronic diseases such as cancer, cardiovascular disease, diabetes, pulmonary respiratory diseases, arthritis have led to the growth of the molecular diagnostics market. Moreover, rise in awareness among people, demand for early diagnostics of diseases, improving healthcare facilities and technological advancements are majorly responsible for the continuous growth of the molecular diagnostics market. According to World Health Organization, infectious diseases kill over 17 million people a year. However, high costs and regulatory hurdles in approval process are the major restrains of the Global Molecular Diagnostics Market. Nonetheless, untapped market and technological advancements may generate new opportunities in forecast period.
Molecular Diagnostics Market Segmentation –
Instruments, Reagents, Services
Infectious Diseases, Chronic Diseases, Genetic Testing, Screening, Pharmacogenomics
Global Molecular Diagnostics Market Regional Analysis –
North America dominates the market with highest market share due to increase in funding by governments and different organizations, rise in number of cases of infectious and chronic diseases and increase in awareness of personalized medicines. In U.S, every year, around 1.7 million Hospital Acquired Infections (HAIs) are encountered, resulting in 99,000 deaths and costing an estimated USD 20 billion. Availability of robust healthcare infrastructure in this region has boosted the demand for molecular diagnostics
Full Research Report @ https://brandessenceresearch.com/healthcare/molecular-diagnostics-market
About us: Brandessence Market Research and Consulting Pvt. Ltd.
Brandessence market research publishes market research reports & business insights produced by highly qualified and experienced industry analysts. Our research reports are available in a wide range of industry verticals including aviation, food & beverage, healthcare, ICT, Construction, Chemicals, and lot more. Brand Essence Market Research report will be best fit for senior executives, business development managers, marketing managers, consultants, CEOs, CIOs, COOs, and Directors, governments, agencies, organizations, and Ph.D. Students. We have a delivery center in Pune, India and our sales office is in London.
Contact us at: +44-2038074155 or mail us at email@example.com
Interested in this report?